Keywords
Acute coronary syndrome
Systematic Review
Case reports
Categories
How to Cite
Abstract
Background: Diabetic ketoacidosis (DKA) and acute coronary syndrome (ACS) represent serious medical emergencies with a complex bidirectional relationship. The clinical presentations and outcomes of these conditions when they co-occur remain incompletely characterized in the literature. We aim to investigate this correlation.
Methods: We systematically searched the PubMed, Scopus, and Web of Science databases, using terms related to acute coronary syndrome (including myocardial infarction, unstable angina, STEMI, and NSTEMI) combined with diabetic ketoacidosis terms, from inception to April 2025, for case reports. The CARE checklist was applied to assess the risk of bias in the included reports.
Results: Twenty-one case reports met inclusion criteria, describing 11 males and 9 females (one unspecified) with a mean age of 51 years. Patients had both type 1 (42.8%) and type 2 (57.1%) diabetes mellitus. Chest pain was the most common presenting symptom (52.3%), but was absent in nearly half of the cases. Six patients (28.5%) on sodium-glucose cotransporter-2 (SGLT2) inhibitors presented with euglycemic DKA. ST-segment elevation was observed in 61.9% of patients, while five patients had normal coronary arteries despite elevated troponin levels. All patients survived after receiving standard DKA management and appropriate cardiac interventions.
Conclusion: This systematic review highlights the importance of maintaining high clinical suspicion for concurrent DKA and ACS, even when typical symptoms such as chest pain or hyperglycemia are absent. We recommend routine cardiac evaluation, including ECG, troponin assessment, and echocardiography, for all DKA patients to ensure early recognition and appropriate management of these potentially life-threatening conditions.
References
1. Ramphul K, Joynauth J. An Update on the Incidence and Burden of Diabetic Ketoacidosis in the U.S. Diabetes Care. 2020: e196 [PMID: 33051332, https://doi.org/10.2337/dc20-1258]
2. Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care. 2018: 1631 [PMID: 29773640, https://doi.org/10.2337/dc17-1379]
3. Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am. 2000: 683 [PMID: 11149157, https://doi.org/10.1016/s0889-8529(05)70159-6]
4. Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am. 1995: 9 [PMID: 7808097, https://doi.org/10.1016/s0025-7125(16)30082-7]
5. Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS. Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025: e865 [PMID: 40163565, https://doi.org/10.1161/CIR.0000000000001328]
6. Sarkees ML, Bavry AA. Acute coronary syndrome (unstable angina and non-ST elevation MI). BMJ Clin Evid. 2009: 0209 [PMID: 19445778,
7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004: 937 [PMID: 15364185, https://doi.org/10.1016/S0140-6736(04)17018-9]
8. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018: 83 [PMID: 29884191, https://doi.org/10.1186/s12933-018-0728-6]
9. Al-Mallah M, Zuberi O, Arida M, Kim HE. Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events. Clin Cardiol. 2008: 67 [PMID: 18257021, https://doi.org/10.1002/clc.20167]
10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021: n71 [PMID: 33782057, https://doi.org/10.1136/bmj.n71]
11. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016: 210 [PMID: 27919275, https://doi.org/10.1186/s13643-016-0384-4]
12. Baral N, Montalbano A, Khan A, Qureshi M, Luitel P. Silent Myocardial Infarction and Acute Multiorgan Failure in a COVID-19 Patient: A Case Report. JNMA J Nepal Med Assoc. 2021: 1048 [PMID: 35199691, https://doi.org/10.31729/jnma.6933]
13. Baytugan NZ, Celik AI, Bezgin T, Cagdas M. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy. Am J Emerg Med. 2023: 250 e1 [PMID: 37451968, https://doi.org/10.1016/j.ajem.2023.07.007]
14. Bouzhir A, Taoufik Benchekroun R, Doghmi N, Zarzur J, Cherti M. Unmasking the Intricate Association Between Takotsubo Syndrome, Atrial Fibrillation, and Diabetes Mellitus: A Case Report and Literature Review. Cureus. 2024: e66516 [PMID: 39252720, https://doi.org/10.7759/cureus.66516]
15. Briggs B, Zitelny E, Zitelny T. Abdominal and Pelvic Computed Tomography for the Diagnosis of ST-Elevation Myocardial Infarction: The Challenges of Acute Coronary Syndrome in Diabetic Patients. Cureus. 2022: e30816 [PMID: 36451633, https://doi.org/10.7759/cureus.30816]
16. Cakir E, Ozbek M, Colak N, Cakal E, Delibasi T. Hypokalemia with ECG Abnormalities Mimicking Acute Coronary Syndrome in a Diabetic Ketoacidotic Patient. Journal of Academic Emergency Medicine Case Reports. 2012: 18 https://doi.org/10.5505/jaemcr.2011.78942]
17. Doherty DJ, Sykes R, Connelly P, Hood S. ST-elevation myocardial infarction due to coronary thrombus in a young patient with diabetic ketoacidosis and a new diagnosis of type 2 diabetes. BMJ Case Rep. 2022: [PMID: 35236686, https://doi.org/10.1136/bcr-2021-247090]
18. Dorcely B, Nitis J, Schwartzbard A, Newman JD, Goldberg IJ, Sum M. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet. Curr Diabetes Rev. 2021: 243 [PMID: 32178617, https://doi.org/10.2174/1573399816666200316112709]
19. Eliades M, El-Maouche D, Choudhary C, Zinsmeister B, Burman KD. Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid. 2014: 383 [PMID: 23560557, https://doi.org/10.1089/thy.2012.0384]
20. Fronczyk A, Molęda P, Majkowska L. Clinical and ECG patterns of pseudoinfarction in a young man with type 1 diabetes, diabetic ketoacidosis and normokalaemia. Clinical Diabetology. 2016: 73 https://doi.org/10.5603/dk.2016.0012]
21. Gerede DM, Kozluca V, Esenboğa K, Aydoğan Bİ, Tutar E. Markedly Elevated Troponin in Diabetic Ketoacidosis without Acute Coronary Syndrome. Turkish Journal of Endocrinology and Metabolism. 2016: 58 https://doi.org/10.4274/tjem.2997]
22. Goto S, Ishikawa JY, Idei M, Iwabuchi M, Namekawa M, Nomura T. Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases. Am J Case Rep. 2021: e929773 [PMID: 33723205, https://doi.org/10.12659/AJCR.929773]
23. Kaefer K, Botta I, Mugisha A, Berdaoui B, De Bels D, Attou R, Honore PM, Redant S. Acute coronary syndrome and diabetic keto acidosis: the chicken or the egg? Ann Transl Med. 2019: 397 [PMID: 31555711, https://doi.org/10.21037/atm.2019.07.38]
24. Landa E, Sharifi S, Abraham J, Vigandt E, Munzinger E. Brugada Pattern Phenocopy Induced by Diabetic Ketoacidosis. Cureus. 2021: e15066 [PMID: 34141510, https://doi.org/10.7759/cureus.15066]
25. Lee HH, Chu CY, Su HM, Lin TH, Voon WC, Lai WT, Sheu SH, Hsu PC. Purulent pericarditis, multi-site abscesses and ketoacidosis in a patient with newly diagnosed diabetes: a rare case report. Diabet Med. 2014: e25 [PMID: 24698085, https://doi.org/10.1111/dme.12458]
26. Mhanna M, Beran A, Srour O, Ghazaleh S, Elzanaty A. A Case of Takotsubo Cardiomyopathy Triggered by Diabetic Ketoacidosis and Hypothermia. Cureus. 2020: e10842 [PMID: 33173648, https://doi.org/10.7759/cureus.10842]
27. Odubanjo AA, Kalisetti R, Adrah R, Ajenifuja A, Joseph B, Zaman M. Severe Myopericarditis in Diabetic Ketoacidosis-All Troponin are Not Myocardial Infarction. Clin Med Insights Case Rep. 2018: 1179547618763356 [PMID: 29568222, https://doi.org/10.1177/1179547618763356]
28. Oriot P, Hermans MP, Beauloye C, Rogghe PA, Noel S, Paternotte E. Unsuspected diabetic ketoacidosis after myocardial infarction in a patient treated with SGLT2 inhibitor increased length of stay in the hospital: how can it be prevented? A case report. Eur Heart J Case Rep. 2023: ytad336 [PMID: 37681058, https://doi.org/10.1093/ehjcr/ytad336]
29. Petersen C, Gyabaah F, Sotelo J, Yohanna S, Deoker A. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old. Cureus. 2023: e45180 [PMID: 37842482, https://doi.org/10.7759/cureus.45180]
30. Umadat G, Moktan V, Shapiro B. 61-Year-Old Man With Nausea and Vomiting. Mayo Clin Proc. 2022: 170 [PMID: 34862073, https://doi.org/10.1016/j.mayocp.2021.04.031]
31. Wray J, Yoo MJ, Bridwell RE, Tannenbaum L, Henderson J. ST-Segment Elevation in the Setting of Diabetic Ketoacidosis: Is It Acute Coronary Syndrome? Cureus. 2020: e7409 [PMID: 32337133, https://doi.org/10.7759/cureus.7409]
32. Zughaib M, Basharat B, Small D. A Case of STEMI-Induced Euglycemic Diabetic Ketoacidosis in a Patient Receiving a Sodium Glucose Cotransporter-2 Inhibitor. JACC Case Rep. 2023: 101792 [PMID: 37077449, https://doi.org/10.1016/j.jaccas.2023.101792]
33. Manikkan AT. Elevated Troponin I Levels in Diabetic Ketoacidosis Without Obstructive Coronary Artery Disease. J Endocr Soc. 2018: 1020 [PMID: 30187014, https://doi.org/10.1210/js.2018-00152]
34. Eubanks A, Raza F, Alkhouli M, Glenn AN, Homko C, Kashem A, Bove A. Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome. Cardiovasc Diabetol. 2012: 154 [PMID: 23270513, https://doi.org/10.1186/1475-2840-11-154]
35. Carrizales-Sepulveda EF, Vera-Pineda R, Jimenez-Castillo RA, Violante-Cumpa JR, Flores-Ramirez R, Ordaz-Farias A. The Heart in Diabetic Ketoacidosis: A Narrative Review Focusing on the Acute Cardiac Effects and Electrocardiographic Abnormalities. Am J Med Sci. 2021: 690 [PMID: 33941367, https://doi.org/10.1016/j.amjms.2020.11.030]
36. Kadel A, Thakur KK, Rauniyar BK, Adhikari RB, Limbu D, Malla R. Acute Myocardial Infarction and Diabetic Ketoacidosis: The Lethal Duo. J Nepal Health Res Counc. 2021: 212 [PMID: 33934164, https://doi.org/10.33314/jnhrc.v19i1.3193]
37. Carrizales-Sepulveda EF, Ordaz-Farias A, Vera-Pineda R, Rodriguez-Gutierrez R, Flores-Ramirez R. Comprehensive echocardiographic and biomarker assessment of patients with diabetic ketoacidosis. Cardiovasc Diabetol. 2024: 385 [PMID: 39468588, https://doi.org/10.1186/s12933-024-02471-0]
38. Ayoub AA, Addas MJ, Alghamdi AA, Alghazzawi N, Bakhsh A, Alharbi T. The Effect of COVID-19 Lockdown on Cerebrovascular Accidents, Acute Coronary Syndrome, and Diabetic Ketoacidosis Visits the Emergency Department: A Retrospective Study. Cureus. 2022: e33154 [PMID: 36601185, https://doi.org/10.7759/cureus.33154]
39. Poojary I, Khalid U, Patra T, Giri J, Al Heyasat A, Basith S, Palasamudram Shekar S, Balachandran A, Haggag A. Troponinemia in Patients With Diabetic Ketoacidosis Without Acute Coronary Syndrome. Cureus. 2024: e61064 [PMID: 38915971, https://doi.org/10.7759/cureus.61064]
40. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005: 786 [PMID: 15867411, https://doi.org/10.7326/0003-4819-142-9-200505030-00015]
41. Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017: e016587 [PMID: 28765134, https://doi.org/10.1136/bmjopen-2017-016587]
42. Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, Wood JR, Lee JM, Willi SM, Cengiz E, Tamborlane WV, Pediatric Diabetes C. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 2016: 266 [PMID: 25951940, https://doi.org/10.1111/pedi.12281]
43. Celik A, Karayakali M, Erkorkmaz U, Altunkas F, Karaman K, Koc F, Ceyhan K, Kadi H, Avsar A. Presence of angina pectoris is related to extensive coronary artery disease in diabetic patients. Clin Cardiol. 2013: 475 [PMID: 23754690, https://doi.org/10.1002/clc.22151]
44. Perona M, Cooklin A, Thorpe C, O'Meara P, Rahman MA. Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review. Eur Cardiol. 2024: e12 [PMID: 39081484, https://doi.org/10.15420/ecr.2023.45]
45. Merkler AE, Bartz TM, Kamel H, Soliman EZ, Howard V, Psaty BM, Okin PM, Safford MM, Elkind MSV, Longstreth WT, Jr. Silent Myocardial Infarction and Subsequent Ischemic Stroke in the Cardiovascular Health Study. Neurology. 2021: e436 [PMID: 34031202, https://doi.org/10.1212/WNL.0000000000012249]
46. Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022: 47 [PMID: 35321742, https://doi.org/10.1186/s12933-022-01476-x]
47. Visser MM, Mathieu C, Gillard P. Diabetic Ketoacidosis After Sodium-Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 Diabetes. Diabetes Technol Ther. 2022: 516 [PMID: 35156849, https://doi.org/10.1089/dia.2021.0553]
48. Levine JA, Karam SL, Aleppo G. SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns. Curr Diab Rep. 2017: 54 [PMID: 28597228, https://doi.org/10.1007/s11892-017-0874-3]
49. Marilly E, Cottin J, Cabrera N, Cornu C, Boussageon R, Moulin P, Lega JC, Gueyffier F, Cucherat M, Grenet G. SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits. Diabetologia. 2022: 2000 [PMID: 35925319, https://doi.org/10.1007/s00125-022-05773-8]
50. Chow E, Clement S, Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2023: [PMID: 37797963, https://doi.org/10.1136/bmjdrc-2023-003666]
51. Barski L, Golbets E, Jotkowitz A, Schwarzfuchs D. Management of diabetic ketoacidosis. Eur J Intern Med. 2023: 38 [PMID: 37419787, https://doi.org/10.1016/j.ejim.2023.07.005]
52. Dunn BK, Coore H, Bongu N, Brewer KL, Kumar D, Malur A, Alkhalisy H. Treatment Challenges and Controversies in the Management of Critically Ill Diabetic Ketoacidosis (DKA) Patients in Intensive Care Units. Cureus. 2024: e68785 [PMID: 39360087, https://doi.org/10.7759/cureus.68785]
53. Patel MP, Ahmed A, Gunapalan T, Hesselbacher SE. Use of sodium bicarbonate and blood gas monitoring in diabetic ketoacidosis: A review. World J Diabetes. 2018: 199 [PMID: 30479686, https://doi.org/10.4239/wjd.v9.i11.199]
54. Wysham C, Preblick R, Zhou FL, Davies M, Paranjape S, Sansgiry S, Xu Q, Joish V. OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry. Journal of the Endocrine Society. 2019: https://doi.org/10.1210/js.2019-OR14-3]
55. Lamsal R, Klyachman L, Adeyinka A, Kondamudi N, Pierre L. Is HbA1c an Indicator of Diabetic Ketoacidosis Severity in the Pediatric Population? Pediatr Emerg Care. 2023: 216 [PMID: 36727771, https://doi.org/10.1097/PEC.0000000000002859]
56. Ekram S. Saeed MDMSKMS, Wael A. Hassib MDYHE-BMD. Value of Glycated Hemoglobin (HbA1c%) as an Indicator of Severity of Acute Coronary Syndrome in Non-Diabetic Adults. The Medical Journal of Cairo University. 2018: 425 https://doi.org/10.21608/mjcu.2018.55142]
57. Wang M, Hng TM. HbA1c: More than just a number. Aust J Gen Pract. 2021: 628 [PMID: 34462769, https://doi.org/10.31128/AJGP-03-21-5866]
58. Guo K, Zhao Q, Wang M, Lu Y, Wo M, Zhou X, Ying C. The Scope of HbA1c Variability and Risk of Vascular Complications Among Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Studies. Horm Metab Res. 2022: 94 [PMID: 35130570, https://doi.org/10.1055/a-1730-4904]
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 ASIDE Internal Medicine